Mikhaila L. Rice, Pharm.D., (@MikhailaPharmD) explains the difference between pre-emptive and prophylaxis strategies for cytomegalovirus infection prevention, selects patients that may benefit from letermovir prophylaxis based on existing literature, and identifies areas of investigational use of letermovir.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.